Vitamin D-containing supplementation and depressive symptom severity in adults: A Bayesian systematic review and evidence-structure assessment.

What It Covers

Researchers studied Vitamin D, K2, Magnesium and Zinc in this systematic review publication.

Vitamin D supplementation has been proposed as a nutrition-related adjunctive strategy for depressive symptoms, but randomized evidence remains heterogeneous, and the feasibility of comparing multicomponent vitamin D-containing regimens is unclear.

The researchers evaluated the effects of vitamin D-containing supplementation on depressive symptom severity in adults and assessed whether the evidence structure supported network or component-level inference.

Who the Included Studies Covered

The age groups tagged for this paper are adults.

Randomized studies of vitamin D-containing nutritional interventions in adults with depressive disorders or clinically relevant depressive symptoms were included.

Treatment-network connectivity and component estimability were assessed before any network or component network meta-analysis was attempted.

How the Review Was Done

The researchers searched PubMed, Embase, CENTRAL, ClinicalTrials.gov, and WHO ICTRP from inception to 15 April 2026.

The primary analysis was a Bayesian random-effects pairwise meta-analysis of endpoint depressive symptom scores in the oral vitamin D evidence layer.

Frequentist endpoint and change-score analyses were used as robustness checks.

What Was Measured

Topics PubMed links to this paper include Dietary Supplements, Bayes Theorem, Vitamin D, Depression and Randomized Controlled Trials as Topic.

The authors tagged it with the keywords Bayesian meta-analysis, Component network meta-analysis, Depressive symptoms, Network feasibility and Nutritional psychiatry.

What This Means in Plain Language

This is a systematic review of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (Clinical nutrition (Edinburgh, Scotland)), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.